Sale of the Product. This Agreement relates solely to the sale of the Product. The parties agree that during the term of this Agreement the Broker-Dealer and the General Agent will not create or sell or participate in the creation or sale of a similar product or a product that would directly or indirectly compete with the Product.
Sale of the Product. (a) X-X hereby agrees that SuperGen shall have the right to sell in the Territory any Inventory bearing the "Xxxxx-Xxxxx" or "Xxxxxx-Xxxxxxx Company" name which may be included in the Assets. SuperGen agrees to maintain any such Inventory under conditions required by the NDA and any other applicable laws and regulations in order to assure that the Product meets all approved specifications at the time of distribution.
(b) SuperGen agrees to use its commercially reasonable efforts to change the labeling of Product packaged after the Closing Date so as to not include any reference to "Xxxxx-Xxxxx" or "Xxxxxx-Xxxxxxx Company", at SuperGen's sole cost and expense. Such change shall take place as soon as reasonably practicable but in no event later than 9 months from the Closing Date.
Sale of the Product. Both Parties agree that the Principal will: - Set the price of the Product. - Provide promotional materials that the Agent will use in their efforts to sell the Product. - Provide a Sales Agreement to the Agent which shall be annexed to this Agreement.
Sale of the Product. 4.1 During the continuance of this Agreement Steroid shall sell such quantities of the Product to Stegram and Bioenvision and Dechra as may be ordered by Stegram or Bioenvision or Dechra, respectively, at any time or from time to time.
4.2 Steroid shall not sell any of the Product to any Person other than the Parties or their respective Designees or successors without each Party's prior written consent and this obligation shall continue beyond termination of this Agreement.
4.3 Under the terms of this Agreement, from time to time, Stegram or Bioenvision or Dechra or Dales shall purchase Product from Steroid. In the routine operation of its business and under the terms of this Agreement, Steroid shall invoice directly Stegram or Bioenvision or Dechra or Dales, as the case may be, for Product delivered to a destination as directed by each such Party. Title to the Product shall be taken by Stegram or Bioenvision or Dechra, or Dales as the case may be, upon delivery of the Product, with payment due, in each case, within sixty (60) days of the date of the related invoice. The invoice will not be dated or shipment arranged until Steroid is notified that the Product is of acceptable quality.
Sale of the Product. Immunex hereby agrees that SuperGen shall have the right to sell in the Territory any Inventory bearing the "Immunex" trademark which may be included in the Purchased Assets. SuperGen agrees to maintain any such Inventory under conditions required by the ANDA and any other applicable laws and regulations in order to assure that the Product meets all approved specifications at the time of distribution.
Sale of the Product. (a) Both Parties shall have the rights to sell a Product and Party A shall be obliged to sell a Product in the PEP Territory;
(b) Any sale of a Product to a third party shall only be carried out after written notice to the other Party as to the quantity of the Product proposed to be sold;
(c) Any sale of the Product to a third party shall be at the sale price and in accordance of the terms of sale of the Product as agreed between the parties in the relevant Product Agreement.
Sale of the Product a) For all orders placed by the Distributor, the Distributor must:
i) pay or cause to be paid to Basis, in the manner or by the means nominated by Barcode Essentials from time to time, the total price for the Product quantity ordered in accordance with the then current Wholesale Price List, including any applicable taxes;
ii) pay invoices issued by Barcode Essentials against the order within 30 days of the invoice date;
iii) pay a late payment fee of 15% of the total invoiced amount for invoices against the order that are not paid within 30 days of the invoice date.
b) The Distributor acknowledges that Barcode Essentials is not required to provide End User access to the Product until the purchase price for the Product has been paid in full, and is entitled to revoke an End User’s access rights if the payment is subsequently dishonoured or required to be refunded to the payer.
c) Without prejudice to any right or cause of action available to Barcode Essentials to revoke End User access to the Product for non-payment by either the End User or the Distributor, and at its sole discretion, Barcode Essentials may provide an End User with access to the Product in advance of payment of the purchase price by the Distributor where Barcode Essentials has approved a credit account for the Distributor and the Distributor has supplied Barcode Essentials with a purchase order for the Product in accordance with requirements of clause 4.
Sale of the Product. ALRT hereby agrees to purchase from TEFE and TEFE hereby agrees to sell to ALRT the Product under the terms and conditions set forth in the schedules agreed to by both parties herein. TEFE agrees not to sell the product directly to any customer of ALRT without ALRT=s written consent.
Sale of the Product. 4.1 During the continuance of this Agreement Sterling shall sell such quantities of the Product to Stegram and Bioenvision and Dechra as may be ordered by Stegram or Bioenvision or Dechra, respectively, at any time or from time to time.
4.2 Sterling shall not sell any of the Product to any Person other than the Parties or their respective Designees or successors without each Party's prior written consent and this obligation shall continue beyond termination of this Agreement.
4.3 Under the terms of this Agreement, from time to time, Stegram or Bioenvision or Dechra shall purchase Product from Sterling. In the routine operation of its business and under the terms of this Agreement, Sterling shall invoice directly Stegram or Bioenvision or Dechra, as the case may be, for Product delivered to a destination as directed by each such Party. Title to the Product shall be taken by Stegram or Bioenvision or Dechra, as the case may be, upon delivery of the Product, with payment due, in each case, within sixty (60) days of the date of the related invoice. The invoice will not be dated or shipment arranged until Sterling is notified that the Product is of acceptable quality. When this Agreement is fully executed Stegram shall immediately provide Sterling with the authorised HPLC methodology. Invoicing and shipping of the Product shall be arranged on the basis of Sterling's HPLC results, when Sterling has demonstrated familiarity with the HPLC methodology. Interest shall be payable by the purchasing Party to Sterling, on payments made more than three (3) days late at the rate of seven percent (7%) unless such late payment is caused by fault of the banks. In the event that such fault is invoked as being the cause of late payment by the purchasing Party, the purchasing Party shall provide evidence to Sterling SNIFF.
Sale of the Product. (a) Both Parties shall have the rights to sell a Product in the Crazy English Territory and Crazy English shall be obliged to sell a Product in the Crazy English Territory;
(b) Any sale of a Product to a third party in the Crazy English Territory shall only be carried out after written notice to the other party as to the quantity of the Product proposed to be sold;
(c) Any sale of the Product to a third party in the Crazy English Territory shall be at the sale price and in accordance of the terms of sale of the Product as agreed between the parties in the relevant Product Agreement.
